A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease
Stahl JM, Walther Z, Chang BW, Hochster HS, Johung KL. A Long-Term Survivor of Metastatic Pancreatic Adenocarcinoma: Free of Recurrence 12 Years After Treatment of Oligometastatic Disease. Cureus 2017, 9: e1007. PMID: 28293485, PMCID: PMC5333949, DOI: 10.7759/cureus.1007.Peer-Reviewed Case Reports and Technical NotesPancreatic ductal adenocarcinomaOligometastatic pancreatic ductal adenocarcinomaMetastatic pancreatic ductal adenocarcinomaAdjuvant gemcitabineResectable pancreatic ductal adenocarcinomaAggressive local therapyRecurrence 12 yearsMultiple liver metastasesAggressive local treatmentMetastatic pancreatic adenocarcinomaLong-term survivorsIdentification of patientsMutations of KRASSmall lung nodulesTime of deathTumor protein p53Oligometastatic diseaseDistant progressionLiver metastasesMetastatic diseaseDisease recurrenceLocal therapyWhipple procedureComplete resolutionAnastomosis site